Knocked Down But Not Out: Recovering From a Refuse to File

A "refusal-to-file" letter typically signals the end of a product's chances of ever getting approved in the US. Some companies, though, have returned from regulatory purgatory to get a review--and even approvals--after meeting FDA's demands.

More from Archive

More from Pink Sheet